160 related articles for article (PubMed ID: 27498997)
1. Discovery of anti-inflammatory role of prostaglandin D
Murata T; Maehara T
J Vet Med Sci; 2016 Dec; 78(11):1643-1647. PubMed ID: 27498997
[TBL] [Abstract][Full Text] [Related]
2. Opposing immunomodulatory roles of prostaglandin D2 during the progression of skin inflammation.
Sarashina H; Tsubosaka Y; Omori K; Aritake K; Nakagawa T; Hori M; Hirai H; Nakamura M; Narumiya S; Urade Y; Ozaki H; Murata T
J Immunol; 2014 Jan; 192(1):459-65. PubMed ID: 24298012
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells.
Xue L; Gyles SL; Wettey FR; Gazi L; Townsend E; Hunter MG; Pettipher R
J Immunol; 2005 Nov; 175(10):6531-6. PubMed ID: 16272307
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of prostaglandin D2 receptors in chronic skin inflammation.
Matsushima Y; Satoh T; Yamamoto Y; Nakamura M; Yokozeki H
Mol Immunol; 2011 Oct; 49(1-2):304-10. PubMed ID: 21943706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of pro-adipogenic effects between prostaglandin (PG) D
Rahman MS; Syeda PK; Nartey MNN; Chowdhury MMI; Shimizu H; Nishimura K; Jisaka M; Shono F; Yokota K
Prostaglandins Other Lipid Mediat; 2018 Nov; 139():71-79. PubMed ID: 30393164
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
Hata AN; Lybrand TP; Marnett LJ; Breyer RM
Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
[TBL] [Abstract][Full Text] [Related]
8. The endogenous bioactive lipid prostaglandin D
Alhouayek M; Buisseret B; Paquot A; Guillemot-Legris O; Muccioli GG
FASEB J; 2018 Sep; 32(9):5000-5011. PubMed ID: 29630407
[TBL] [Abstract][Full Text] [Related]
9. Activated prostaglandin D2 receptors on macrophages enhance neutrophil recruitment into the lung.
Jandl K; Stacher E; Bálint Z; Sturm EM; Maric J; Peinhaupt M; Luschnig P; Aringer I; Fauland A; Konya V; Dahlen SE; Wheelock CE; Kratky D; Olschewski A; Marsche G; Schuligoi R; Heinemann A
J Allergy Clin Immunol; 2016 Mar; 137(3):833-43. PubMed ID: 26792210
[TBL] [Abstract][Full Text] [Related]
10. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
11. Opposing roles of prostaglandin D2 receptors in ulcerative colitis.
Sturm EM; Radnai B; Jandl K; Stančić A; Parzmair GP; Högenauer C; Kump P; Wenzl H; Petritsch W; Pieber TR; Schuligoi R; Marsche G; Ferreirós N; Heinemann A; Schicho R
J Immunol; 2014 Jul; 193(2):827-39. PubMed ID: 24929001
[TBL] [Abstract][Full Text] [Related]
12. Expression and molecular pharmacology of the mouse CRTH2 receptor.
Hata AN; Zent R; Breyer MD; Breyer RM
J Pharmacol Exp Ther; 2003 Aug; 306(2):463-70. PubMed ID: 12721327
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.
Gallant MA; Slipetz D; Hamelin E; Rochdi MD; Talbot S; de Brum-Fernandes AJ; Parent JL
Eur J Pharmacol; 2007 Feb; 557(2-3):115-23. PubMed ID: 17207480
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of PGD2 receptors in chronic rhinosinusitis: modulation of DP and CRTH2 by PGD2.
Yamamoto M; Okano M; Fujiwara T; Kariya S; Higaki T; Nagatsuka H; Tsujigiwa H; Yamada M; Yoshino T; Urade Y; Nishizaki K
Int Arch Allergy Immunol; 2009; 148(2):127-36. PubMed ID: 18802357
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
[TBL] [Abstract][Full Text] [Related]
16. Presence and characterization of prostaglandin D2-related molecules in nasal mucosa of patients with allergic rhinitis.
Okano M; Fujiwara T; Sugata Y; Gotoh D; Masaoka Y; Sogo M; Tanimoto W; Yamamoto M; Matsumoto R; Eguchi N; Kiniwa M; Isik AU; Urade Y; Nishizaki K
Am J Rhinol; 2006; 20(3):342-8. PubMed ID: 16871941
[TBL] [Abstract][Full Text] [Related]
17. Dual functions of prostaglandin D2 in murine contact hypersensitivity via DP and CRTH2.
Yamamoto Y; Otani S; Hirai H; Nagata K; Aritake K; Urade Y; Narumiya S; Yokozeki H; Nakamura M; Satoh T
Am J Pathol; 2011 Jul; 179(1):302-14. PubMed ID: 21703412
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases.
Mitsumori S
Curr Pharm Des; 2004; 10(28):3533-8. PubMed ID: 15579050
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
20. Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors.
Grill M; Heinemann A; Hoefler G; Peskar BA; Schuligoi R
J Neurochem; 2008 Mar; 104(5):1345-57. PubMed ID: 18028337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
